Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,504 | -17,984 | -38,837 | -14,185 | -9,648 |
| Depreciation Amortization | 446 | -1,388 | 19,480 | 382 | 336 |
| Accounts receivable | N/A | N/A | N/A | 556 | 88 |
| Other Working Capital | 140 | 2,342 | -2,712 | 170 | -1,057 |
| Other Operating Activity | 433 | 2,364 | 634 | 358 | 451 |
| Operating Cash Flow | $-16,485 | $-14,666 | $-21,435 | $-12,719 | $-9,830 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8 | -118 | -74 | -52 | -240 |
| Investing Cash Flow | $-8 | $-118 | $-74 | $-52 | $-240 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 4,000 | N/A | 38,505 | 35,783 |
| Other Financing Activity | 0 | -7 | -27 | -39 | -121 |
| Financing Cash Flow | $N/A | $3,993 | $-27 | $38,466 | $35,662 |
| Beginning Cash Position | 26,428 | 37,219 | 58,755 | 33,060 | 7,468 |
| End Cash Position | 9,935 | 26,428 | 37,219 | 58,755 | 33,060 |
| Net Cash Flow | $-16,493 | $-10,791 | $-21,536 | $25,695 | $25,592 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,485 | -14,666 | -21,435 | -12,719 | -9,830 |
| Capital Expenditure | -8 | -118 | -74 | -52 | -240 |
| Free Cash Flow | -16,493 | -14,784 | -21,509 | -12,771 | -10,070 |